Executive Committee Members

Dr. Raouf Arafat, MD, MPH

Dr. Arafat, Assistant Director of the Houston Health Department

Dr. Arafat is the Assistant Director of the Houston Health Department and the Director of the Office of Surveillance and Public Health Preparedness. He is a veteran administrator with decades of experience managing local, state, and federal programs and has also functioned as the Principal Investigator in many surveillance and research projects. His current responsibilities include directing the analysis of disease trends in Houston, Texas, and advising for appropriate public health actions and research. Furthermore, he is involved in synchronizing logistics for collection and dissemination of technical and scientific information as well as epidemiologic information relevant to the impact and control of diseases of public health importance in the Houston area. Dr. Arafat has worked in partnership with other researchers, co-authored peer-reviewed publications and has been instrumental in organizing collaborations with external organizations. He serves as adjunct faculty at the University of Texas, School of Public Health and at the Baylor College of Medicine, National School of Tropical Medicine, and as an Advisory Board Member at the Center for Biosecurity and Public Health Informatics Research at the University of Texas School of Biomedical Informatics.

Edward J. Septimus, M.D., F.I.D.S.A, F.A.C.P, F.S.H.E.A.

Dr.Ed Septimus, VP for Research and Infectious Diseases Hospital Corporation of America (HCA).

Dr. Ed Septimus received his medical degree from Baylor College of Medicine in Houston in 1972. Dr. Septimus went on to complete his postgraduate training in internal medicine and infectious diseases at Baylor College of Medicine in Houston. Dr. Ed Septimus is board certified in both internal medicine and infectious diseases. His current position is VP for Research and Infectious Diseases Hospital Corporation of America (HCA). He served on the Board of Directors of the Infectious Diseases Society of America (IDSA) and is on the IDSA Antimicrobial Resistance Committee, the SHEA Antimicrobial Stewardship Committee, and the IDSA Quality Measurement Committee. He is on the Scientific Committee for MAD-ID. In 2011 he was appointed to the Healthcare-Associated Infections/Preventable Adverse Events Advisory Panel for the Texas Department of State Health Services. He was the first recipient of the IDSA Annual Clinician Award. He was awarded the John S Dunn Sr. Outstanding Teacher Award in 2010, 2011, 2013 and 2014. He was on the FDA Anti-Infective Drug Advisory Group and is co-chairs of the NQF Patient Safety Steering Committee. He holds a faculty position as Clinical Professor at Texas A&M Medical School and Professor, Distinguished Senior Fellow, School of Public Health, George Mason University. He has published over 100 articles and chapters.

Kevin Garey, PharmD

Kevin Garey

Kevin Garey is a Professor at the University of Houston College of Pharmacy and Chair of the Department of Pharmacy Practice and Translational Research. He is an Adjunct Professor at the University of Texas School of Public Health and a Clinical Specialist and Researcher at Baylor St. Luke’s Medical Center, Houston, Texas. He received a Bachelor of Science in Pharmacy degree from Dalhousie University in Halifax, Nova Scotia, Canada, a Doctor of Pharmacy from SUNY Buffalo in Buffalo, NY, and a Masters of Science in Biometry from the University of Texas School of Public Health. Postdoctoral training includes a pharmacy practice residency at Bassett Healthcare, Cooperstown, NY and infectious disease specialty residency and fellowship training at the University of Illinois at Chicago, Chicago, IL. Dr. Garey's research interests involve clinical and translational research involving healthcare-associated infections including post-surgical infections, candidemia, and Clostridium difficile infection.

Dr. Kristi Kuper, PharmD, BCPS

Kristi Kuper, Senior Clinical Manager of Infectious Diseases for Vizient

Dr. Kristi Kuper is currently a Senior Clinical Manager of Infectious Diseases for Vizient (formerly UHC/VHA). She has spent the majority of her 18 year career working in antibiotic stewardship with a specific focus on program implementation resource challenged settings. To date, she has worked in various capacities with over 350 hospitals nationwide and developed an antibiotic stewardship training program which has been completed by over 1000 participants. Dr. Kuper has served on a number of committees related to antimicrobial stewardship, including past CDC and Pew Trust workgroups on inpatient antibiotic stewardship, the IHI Antimicrobial Stewardship Driver Diagram development committee, the NQF Antibiotic Stewardship Playbook. She currently serves on the ASHP and SHEA National Antibiotic Stewardship Subcommittees and is a co-founder of the Houston Citywide Antibiotic Stewardship symposium which began in 2015. Finally, she was an invited attendee at the White House Forum on Antibiotic Stewardship in June 2015. She received her Doctor of Pharmacy degree from the University of Nebraska Medical Center and completed a pharmacy practice residency at the James A Haley VA in Tampa, Florida.